CoviVac
Vaccineexperimental
Clinical trial activity
6 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
6
Phase 3
2
Phase 4
0
Earliest trial started Oct 3, 2020 (NCT05046548)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05715918 | Phase 3 | Apr 1, 2022 | Government of Russia |
| NCT05940194 | Phase 2 | Aug 11, 2021 | Government of Vietnam, Institute of Vaccines and Medical Biologicals, Vietnam |
| NCT05407142 | Phase 3 | Jul 7, 2021 | Government of Russia |
| NCT05765773 | Phase 2 | Jul 1, 2021 | Government of Russia |
| NCT04830800 | Phase 1/Phase 2 (Phase 2) | Mar 10, 2021 | Government of Thailand, Government of Vietnam, Hanoi Medical University, Institute of Vaccines and Medical Biologicals, Vietnam |
| NCT05046548 | Phase 1/Phase 2 (Phase 2) | Oct 3, 2020 | Government of Russia |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 4 | 4 | 2 | 2020 |
| Government of Vietnam | Government | 2 | 0 | 1 | 2021 |
| Institute of Vaccines and Medical Biologicals, Vietnam | Government | 2 | 2 | 1 | 2021 |
| Government of Thailand | Government | 1 | 0 | 1 | 2021 |
| Hanoi Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
5 organizations
Page 1 / 1